TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3.Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2.Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL REAL-WORLD EVIDENCE MARKET, BY COMPONENTS
6.1. Overview
6.2. Services
6.3. Data sets
6.3.1. Disparate Data Sets
6.3.1.1. Clinical Setting Data Sets
6.3.1.2. Claims Data Set
6.3.1.3. Pharmacy Data Set
6.3.1.4. Patient-powered Data Set
6.3.1.5. Registry-Based Data Sets
6.4. Integrated Data sets
7. GLOBAL REAL-WORLD EVIDENCE MARKET, BY APPLICATION
7.1. Overview
7.2. Drug Development and Approvals
7.2.1. Oncology
7.2.2. Cardiovascular Disease
7.2.3. Neurology
7.2.4. Immunology
7.2.5. Other therapeutic areas
7.3. Medical Device Development and Approvals
7.4. Post-Market Surveillance
7.5. Market Access and Reimbursement Coverage Decision Making and Clinical
7.6. Clinical and Regulatory Decision Making
7.7. Others
8. GLOBAL REAL-WORLD EVIDENCE MARKET, BY MODE OF DEPLOYMENT
8.1. Overview
8.2. On-premises
8.3. Cloud Based
9. GLOBAL REAL-WORLD EVIDENCE MARKET, BY REVENUE MODEL
9.1. Overview
9.2. Pay Per Usage
9.3. Subscription
10. GLOBAL REAL-WORLD EVIDENCE MARKET, BY END USERS
10.1. Overview
10.2. Pharmaceutical & Medical Device Companies
10.3. Healthcare Payers
10.4. Healthcare Providers
10.5. Other End Users
11. GLOBAL REAL-WORLD EVIDENCE MARKET, BY REGION
11.1. Overview
11.1. North America
11.1.1. US
11.1.2. Canada
11.2. Europe
11.2.1. Germany
11.2.2. France
11.2.3. UK
11.2.4. Italy
11.2.5. Spain
11.2.6. Rest of Europe
11.3. Asia-Pacific
11.3.1. China
11.3.2. India
11.3.3. Japan
11.3.4. South Korea
11.3.5. Australia
11.3.6. Rest of Asia-Pacific
11.4. Rest of the World
11.4.1. Middle East
11.4.2. Africa
11.4.3. Latin America
12. COMPETITIVE LANDSCAPE
12.1. Overview
12.2. Competitive Analysis
12.3. Market Share Analysis
12.4. Major Growth Strategy in the Global REAL-WORLD EVIDENCE Market,
12.5. Competitive Benchmarking
12.6. Leading Players in Terms of Number of Developments in the Global REAL-WORLD EVIDENCE Market,
12.7. Key developments and Growth Strategies
12.7.1. New Product Launch/Service Deployment
12.7.2. Merger & Acquisitions
12.7.3. Joint Ventures
12.8. Major Players Financial Matrix
12.8.1. Sales & Operating Income, 2023
12.8.2. Major Players R&D Expenditure. 2023
13. COMPANY PROFILES
13.1. IQVIA
13.1.1. Company Overview
13.1.2. Financial Overview
13.1.3. Products Offered
13.1.4. Key Developments
13.1.5. SWOT Analysis
13.1.6. Key Strategies
13.2. Optum
13.2.1. Company Overview
13.2.2. Financial Overview
13.2.3. Products Offered
13.2.4. Key Developments
13.2.5. SWOT Analysis
13.2.6. Key Strategies
13.3. IBM Watson Health
13.3.1. Company Overview
13.3.2. Financial Overview
13.3.3. Products Offered
13.3.4. Key Developments
13.3.5. SWOT Analysis
13.3.6. Key Strategies
13.4. Cerner Corporation
13.4.1. Company Overview
13.4.2. Financial Overview
13.4.3. Products Offered
13.4.4. Key Developments
13.4.5. SWOT Analysis
13.4.6. Key Strategies
13.5. SAS Institute Inc.
13.5.1. Company Overview
13.5.2. Financial Overview
13.5.3. Products Offered
13.5.4. Key Developments
13.5.5. SWOT Analysis
13.5.6. Key Strategies
13.6. Oracle Corporation
13.6.1. Company Overview
13.6.2. Financial Overview
13.6.3. Products Offered
13.6.4. Key Developments
13.6.5. SWOT Analysis
13.6.6. Key Strategies
13.7. Syneos Health
13.7.1. Company Overview
13.7.2. Financial Overview
13.7.3. Products Offered
13.7.4. Key Developments
13.7.5. SWOT Analysis
13.7.6. Key Strategies
13.8. FLATIRON HEALTH
13.8.1. Company Overview
13.8.2. Financial Overview
13.8.3. Products Offered
13.8.4. Key Developments
13.8.5. SWOT Analysis
13.8.6. Key Strategies
13.9. Palantir Technologies
13.9.1. Company Overview
13.9.2. Financial Overview
13.9.3. Products Offered
13.9.4. Key Developments
13.9.5. SWOT Analysis
13.9.6. Key Strategies
13.10. CLINITHINK
13.10.1. Company Overview
13.10.2. Financial Overview
13.10.3. Products Offered
13.10.4. Key Developments
13.10.5. SWOT Analysis
13.10.6. Key Strategies
14. APPENDIX
14.1. References
14.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL REAL-WORLD EVIDENCE MARKET, SYNOPSIS, 2019-2032
TABLE 2 GLOBAL REAL-WORLD EVIDENCE MARKET, ESTIMATES & FORECAST, 2019-2032 (USD BILLION)
TABLE 3 GLOBAL REAL-WORLD EVIDENCE MARKET, BY COMPONENTS, 2019-2032 (USD BILLION)
TABLE 4 GLOBAL REAL-WORLD EVIDENCE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 5 GLOBAL REAL-WORLD EVIDENCE MARKET, BY MODE OF DEPLOYMENT, 2019-2032 (USD BILLION)
TABLE 6 GLOBAL REAL-WORLD EVIDENCE MARKET, BY REVENUE MODEL, 2019-2032 (USD BILLION)
TABLE 7 GLOBAL REAL-WORLD EVIDENCE MARKET, BY END USERS, 2019-2032 (USD BILLION)
TABLE 8 NORTH AMERICA: REAL-WORLD EVIDENCE MARKET, BY COMPONENTS, 2019-2032 (USD BILLION)
TABLE 9 NORTH AMERICA: REAL-WORLD EVIDENCE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 10 NORTH AMERICA: REAL-WORLD EVIDENCE MARKET, BY MODE OF DEPLOYMENT, 2019-2032 (USD BILLION)
TABLE 11 NORTH AMERICA: REAL-WORLD EVIDENCE MARKET, BY REVENUE MODEL, 2019-2032 (USD BILLION)
TABLE 12 NORTH AMERICA: REAL-WORLD EVIDENCE MARKET, BY END USERS, 2019-2032 (USD BILLION)
TABLE 13 US: REAL-WORLD EVIDENCE MARKET, BY COMPONENTS, 2019-2032 (USD BILLION)
TABLE 14 US: REAL-WORLD EVIDENCE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 15 US: REAL-WORLD EVIDENCE MARKET, BY MODE OF DEPLOYMENT, 2019-2032 (USD BILLION)
TABLE 16 US: REAL-WORLD EVIDENCE MARKET, BY REVENUE MODEL, 2019-2032 (USD BILLION)
TABLE 17 US: REAL-WORLD EVIDENCE MARKET, BY END USERS, 2019-2032 (USD BILLION)
TABLE 18 CANADA: REAL-WORLD EVIDENCE MARKET, BY COMPONENTS, 2019-2032 (USD BILLION)
TABLE 19 CANADA: REAL-WORLD EVIDENCE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 20 CANADA: REAL-WORLD EVIDENCE MARKET, BY MODE OF DEPLOYMENT, 2019-2032 (USD BILLION)
TABLE 21 CANADA: REAL-WORLD EVIDENCE MARKET, BY REVENUE MODEL, 2019-2032 (USD BILLION)
TABLE 22 CANADA: REAL-WORLD EVIDENCE MARKET, BY END USERS, 2019-2032 (USD BILLION)
TABLE 23 EUROPE: REAL-WORLD EVIDENCE MARKET, BY COMPONENTS, 2019-2032 (USD BILLION)
TABLE 24 EUROPE: REAL-WORLD EVIDENCE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 25 EUROPE: REAL-WORLD EVIDENCE MARKET, BY MODE OF DEPLOYMENT, 2019-2032 (USD BILLION)
TABLE 26 EUROPE: REAL-WORLD EVIDENCE MARKET, BY REVENUE MODEL, 2019-2032 (USD BILLION)
TABLE 27 EUROPE: REAL-WORLD EVIDENCE MARKET, BY END USERS, 2019-2032 (USD BILLION)
TABLE 28 GERMANY: REAL-WORLD EVIDENCE MARKET, BY COMPONENTS, 2019-2032 (USD BILLION)
TABLE 29 GERMANY: REAL-WORLD EVIDENCE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 30 GERMANY: REAL-WORLD EVIDENCE MARKET, BY MODE OF DEPLOYMENT, 2019-2032 (USD BILLION)
TABLE 31 GERMANY: REAL-WORLD EVIDENCE MARKET, BY REVENUE MODEL, 2019-2032 (USD BILLION)
TABLE 32 GERMANY: REAL-WORLD EVIDENCE MARKET, BY END USERS, 2019-2032 (USD BILLION)
TABLE 33 FRANCE: REAL-WORLD EVIDENCE MARKET, BY COMPONENTS, 2019-2032 (USD BILLION)
TABLE 34 FRANCE: REAL-WORLD EVIDENCE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 35 FRANCE: REAL-WORLD EVIDENCE MARKET, BY MODE OF DEPLOYMENT, 2019-2032 (USD BILLION)
TABLE 36 FRANCE: REAL-WORLD EVIDENCE MARKET, BY REVENUE MODEL, 2019-2032 (USD BILLION)
TABLE 37 FRANCE: REAL-WORLD EVIDENCE MARKET, BY END USERS, 2019-2032 (USD BILLION)
TABLE 38 ITALY: REAL-WORLD EVIDENCE MARKET, BY COMPONENTS, 2019-2032 (USD BILLION)
TABLE 39 ITALY: REAL-WORLD EVIDENCE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 40 ITALY: REAL-WORLD EVIDENCE MARKET, BY MODE OF DEPLOYMENT, 2019-2032 (USD BILLION)
TABLE 41 ITALY: REAL-WORLD EVIDENCE MARKET, BY REVENUE MODEL, 2019-2032 (USD BILLION)
TABLE 42 ITALY: REAL-WORLD EVIDENCE MARKET, BY END USERS, 2019-2032 (USD BILLION)
TABLE 43 SPAIN: REAL-WORLD EVIDENCE MARKET, BY COMPONENTS, 2019-2032 (USD BILLION)
TABLE 44 SPAIN: REAL-WORLD EVIDENCE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 45 SPAIN: REAL-WORLD EVIDENCE MARKET, BY MODE OF DEPLOYMENT, 2019-2032 (USD BILLION)
TABLE 46 SPAIN: REAL-WORLD EVIDENCE MARKET, BY REVENUE MODEL, 2019-2032 (USD BILLION)
TABLE 47 SPAIN: REAL-WORLD EVIDENCE MARKET, BY END USERS, 2019-2032 (USD BILLION)
TABLE 48 UK: REAL-WORLD EVIDENCE MARKET, BY COMPONENTS, 2019-2032 (USD BILLION)
TABLE 49 UK: REAL-WORLD EVIDENCE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 50 UK: REAL-WORLD EVIDENCE MARKET, BY MODE OF DEPLOYMENT, 2019-2032 (USD BILLION)
TABLE 51 UK: REAL-WORLD EVIDENCE MARKET, BY REVENUE MODEL, 2019-2032 (USD BILLION)
TABLE 52 UK: REAL-WORLD EVIDENCE MARKET, BY END USERS, 2019-2032 (USD BILLION)
TABLE 53 REST OF EUROPE: REAL-WORLD EVIDENCE MARKET, BY COMPONENTS, 2019-2032 (USD BILLION)
TABLE 54 REST OF EUROPE: REAL-WORLD EVIDENCE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 55 REST OF EUROPE: REAL-WORLD EVIDENCE MARKET, BY MODE OF DEPLOYMENT, 2019-2032 (USD BILLION)
TABLE 56 REST OF EUROPE: REAL-WORLD EVIDENCE MARKET, BY REVENUE MODEL, 2019-2032 (USD BILLION)
TABLE 57 REST OF EUROPE: REAL-WORLD EVIDENCE MARKET, BY END USERS, 2019-2032 (USD BILLION)
TABLE 58 ASIA-PACIFIC: REAL-WORLD EVIDENCE MARKET, BY COMPONENTS, 2019-2032 (USD BILLION)
TABLE 59 ASIA-PACIFIC: REAL-WORLD EVIDENCE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 60 ASIA-PACIFIC: REAL-WORLD EVIDENCE MARKET, BY MODE OF DEPLOYMENT, 2019-2032 (USD BILLION)
TABLE 61 ASIA-PACIFIC: REAL-WORLD EVIDENCE MARKET, BY REVENUE MODEL, 2019-2032 (USD BILLION)
TABLE 62 ASIA-PACIFIC: REAL-WORLD EVIDENCE MARKET, BY END USERS, 2019-2032 (USD BILLION)
TABLE 63 JAPAN: REAL-WORLD EVIDENCE MARKET, BY COMPONENTS, 2019-2032 (USD BILLION)
TABLE 64 JAPAN: REAL-WORLD EVIDENCE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 65 JAPAN: REAL-WORLD EVIDENCE MARKET, BY MODE OF DEPLOYMENT, 2019-2032 (USD BILLION)
TABLE 66 JAPAN: REAL-WORLD EVIDENCE MARKET, BY REVENUE MODEL, 2019-2032 (USD BILLION)
TABLE 67 JAPAN: REAL-WORLD EVIDENCE MARKET, BY END USERS, 2019-2032 (USD BILLION)
TABLE 68 CHINA: REAL-WORLD EVIDENCE MARKET, BY COMPONENTS, 2019-2032 (USD BILLION)
TABLE 69 CHINA: REAL-WORLD EVIDENCE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 70 CHINA: REAL-WORLD EVIDENCE MARKET, BY MODE OF DEPLOYMENT, 2019-2032 (USD BILLION)
TABLE 71 CHINA: REAL-WORLD EVIDENCE MARKET, BY REVENUE MODEL, 2019-2032 (USD BILLION)
TABLE 72 CHINA: REAL-WORLD EVIDENCE MARKET, BY END USERS, 2019-2032 (USD BILLION)
TABLE 73 INDIA: REAL-WORLD EVIDENCE MARKET, BY COMPONENTS, 2019-2032 (USD BILLION)
TABLE 74 INDIA: REAL-WORLD EVIDENCE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 75 INDIA: REAL-WORLD EVIDENCE MARKET, BY MODE OF DEPLOYMENT, 2019-2032 (USD BILLION)
TABLE 76 INDIA: REAL-WORLD EVIDENCE MARKET, BY REVENUE MODEL, 2019-2032 (USD BILLION)
TABLE 77 INDIA: REAL-WORLD EVIDENCE MARKET, BY END USERS, 2019-2032 (USD BILLION)
TABLE 78 AUSTRALIA: REAL-WORLD EVIDENCE MARKET, BY COMPONENTS, 2019-2032 (USD BILLION)
TABLE 79 AUSTRALIA: REAL-WORLD EVIDENCE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 80 AUSTRALIA: REAL-WORLD EVIDENCE MARKET, BY MODE OF DEPLOYMENT, 2019-2032 (USD BILLION)
TABLE 81 AUSTRALIA: REAL-WORLD EVIDENCE MARKET, BY REVENUE MODEL, 2019-2032 (USD BILLION)
TABLE 82 AUSTRALIA: REAL-WORLD EVIDENCE MARKET, BY END USERS, 2019-2032 (USD BILLION)
TABLE 83 SOUTH KOREA: REAL-WORLD EVIDENCE MARKET, BY COMPONENTS, 2019-2032 (USD BILLION)
TABLE 84 SOUTH KOREA: REAL-WORLD EVIDENCE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 85 SOUTH KOREA: REAL-WORLD EVIDENCE MARKET, BY MODE OF DEPLOYMENT, 2019-2032 (USD BILLION)
TABLE 86 SOUTH KOREA: REAL-WORLD EVIDENCE MARKET, BY REVENUE MODEL, 2019-2032 (USD BILLION)
TABLE 87 SOUTH KOREA: REAL-WORLD EVIDENCE MARKET, BY END USERS, 2019-2032 (USD BILLION)
TABLE 88 REST OF ASIA-PACIFIC: REAL-WORLD EVIDENCE MARKET, BY COMPONENTS, 2019-2032 (USD BILLION)
TABLE 89 REST OF ASIA-PACIFIC: REAL-WORLD EVIDENCE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 90 REST OF ASIA-PACIFIC: REAL-WORLD EVIDENCE MARKET, BY MODE OF DEPLOYMENT, 2019-2032 (USD BILLION)
TABLE 91 REST OF ASIA-PACIFIC: REAL-WORLD EVIDENCE MARKET, BY REVENUE MODEL, 2019-2032 (USD BILLION)
TABLE 92 REST OF ASIA-PACIFIC: REAL-WORLD EVIDENCE MARKET, BY END USERS, 2019-2032 (USD BILLION)
TABLE 93 REST OF THE WORLD: REAL-WORLD EVIDENCE MARKET, BY COMPONENTS, 2019-2032 (USD BILLION)
TABLE 94 REST OF THE WORLD: REAL-WORLD EVIDENCE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 95 REST OF THE WORLD: REAL-WORLD EVIDENCE MARKET, BY MODE OF DEPLOYMENT, 2019-2032 (USD BILLION)
TABLE 96 REST OF THE WORLD: REAL-WORLD EVIDENCE MARKET, BY REVENUE MODEL, 2019-2032 (USD BILLION)
TABLE 97 REST OF THE WORLD: REAL-WORLD EVIDENCE MARKET, BY END USERS, 2019-2032 (USD BILLION)
TABLE 98 MIDDLE EAST: REAL-WORLD EVIDENCE MARKET, BY COMPONENTS, 2019-2032 (USD BILLION)
TABLE 99 MIDDLE EAST: REAL-WORLD EVIDENCE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 100 MIDDLE EAST: REAL-WORLD EVIDENCE MARKET, BY MODE OF DEPLOYMENT, 2019-2032 (USD BILLION)
TABLE 101 MIDDLE EAST: REAL-WORLD EVIDENCE MARKET, BY REVENUE MODEL, 2019-2032 (USD BILLION)
TABLE 102 MIDDLE EAST: REAL-WORLD EVIDENCE MARKET, BY END USERS, 2019-2032 (USD BILLION)
TABLE 103 AFRICA: REAL-WORLD EVIDENCE MARKET, BY COMPONENTS, 2019-2032 (USD BILLION)
TABLE 104 AFRICA: REAL-WORLD EVIDENCE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 105 AFRICA: REAL-WORLD EVIDENCE MARKET, BY MODE OF DEPLOYMENT, 2019-2032 (USD BILLION)
TABLE 106 AFRICA: REAL-WORLD EVIDENCE MARKET, BY REVENUE MODEL, 2019-2032 (USD BILLION)
TABLE 107 AFRICA: REAL-WORLD EVIDENCE MARKET, BY END USERS, 2019-2032 (USD BILLION)
TABLE 108 LATIN AMERICA: REAL-WORLD EVIDENCE MARKET, BY COMPONENTS, 2019-2032 (USD BILLION)
TABLE 109 LATIN AMERICA: REAL-WORLD EVIDENCE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 110 LATIN AMERICA: REAL-WORLD EVIDENCE MARKET, BY MODE OF DEPLOYMENT, 2019-2032 (USD BILLION)
TABLE 111 LATIN AMERICA: REAL-WORLD EVIDENCE MARKET, BY REVENUE MODEL, 2019-2032 (USD BILLION)
TABLE 112 LATIN AMERICA: REAL-WORLD EVIDENCE MARKET, BY END USERS, 2019-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL REAL-WORLD EVIDENCE MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL REAL-WORLD EVIDENCE MARKET
FIGURE 4 GLOBAL REAL-WORLD EVIDENCE MARKET, SHARE (%), BY COMPONENTS, 2023
FIGURE 5 GLOBAL REAL-WORLD EVIDENCE MARKET, SHARE (%), BY APPLICATION, 2023
FIGURE 6 GLOBAL REAL-WORLD EVIDENCE MARKET, SHARE (%), BY MODE OF DEPLOYMENT, 2023
FIGURE 7 GLOBAL REAL-WORLD EVIDENCE MARKET, SHARE (%), BY REVENUE MODEL, 2023
FIGURE 8 GLOBAL REAL-WORLD EVIDENCE MARKET, SHARE (%), BY END USERS, 2023
FIGURE 9 GLOBAL REAL-WORLD EVIDENCE MARKET, SHARE (%), BY REGION, 2023
FIGURE 10 NORTH AMERICA: REAL-WORLD EVIDENCE MARKET, SHARE (%), BY REGION, 2023
FIGURE 11 EUROPE: REAL-WORLD EVIDENCE MARKET, SHARE (%), BY REGION, 2023
FIGURE 12 ASIA-PACIFIC: REAL-WORLD EVIDENCE MARKET, SHARE (%), BY REGION, 2023
FIGURE 13 REST OF THE WORLD: REAL-WORLD EVIDENCE MARKET, SHARE (%), BY REGION, 2023
FIGURE 14 GLOBAL REAL-WORLD EVIDENCE MARKET: COMPANY SHARE ANALYSIS, 2023 (%)
FIGURE 15 IQVIA: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 16 IQVIA: SWOT ANALYSIS
FIGURE 17 OPTUM: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 18 OPTUM: SWOT ANALYSIS
FIGURE 19 IBM WATSON HEALTH: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 20 IBM WATSON HEALTH: SWOT ANALYSIS
FIGURE 21 CERNER CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 22 CERNER CORPORATION: SWOT ANALYSIS
FIGURE 23 SAS INSTITUTE INC..: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 24 SAS INSTITUTE INC..: SWOT ANALYSIS
FIGURE 25 ORACLE CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 ORACLE CORPORATION: SWOT ANALYSIS
FIGURE 27 SYNEOS HEALTH: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 SYNEOS HEALTH: SWOT ANALYSIS
FIGURE 29 FLATIRON HEALTH: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 30 FLATIRON HEALTH: SWOT ANALYSIS
FIGURE 31 PALANTIR TECHNOLOGIES: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 32 PALANTIR TECHNOLOGIES: SWOT ANALYSIS
FIGURE 33 CLINITHINK: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 34 CLINITHINK: SWOT ANALYSIS
